Listen to Roger Bedimo, MD, MS, FACP, describe the current status of PrEP uptake in the United States, address potential reasons for PrEP inequity, and discuss strategies to overcome health disparities to increase PrEP initiation.

Listen as Roger Bedimo, MD, MS, FACP, examines provider-based and structural PrEP barriers and discusses practical methods for healthcare professionals to overcome these challenges.

Listen as experts discuss their approaches to evaluating whether each person living with HIV is taking the best ART regimen for them, as well as ways to proactively assess challenges people may be facing with their HIV ART.

Listen to Jonathan Appelbaum, MD, FACP, AAHIVS, discuss updated CDC guidance on why and how to monitor for HIV in people receiving LA PrEP.

Listen to Jonathan Appelbaum, MD, FACP, AAHIVS, discuss the newest data supporting LA ART use in people with adherence challenges or viremia, including the LATITUDE study, updates to the Ward 86 cohort, and the CARES study.

In this episode, Angela Branche, MD, FIDSA, and Jewel Mullen, MD, MPH, MPA, FACP, address common questions about RSV vaccination, including determining vaccine candidacy, considerations for vaccine timing and administration, addressing vaccine safety, and information on vaccine coverage.

In this episode, Jewel Mullen, MD, MPH, MPA, FACP, shares strategies for implementing RSV vaccines into practice and how using shared clinical decision-making can build vaccine confidence in both patients and healthcare professionals.

Listen as Angela Branche, MD, FIDSA, discusses RSV disease burden, symptoms and complications of RSV infection, and risk factors for severe RSV disease.

Robert H. Hopkins, Jr., MD, MACP, and Laura P. Hurley, MD, MPH, discuss the risk for and burden of shingles, current vaccine recommendations, best practices to improve shingles vaccine uptake, and what insurance-related concerns may need to be addressed.

Listen as Samantha Strong, PharmD, BCACP, AAHIVP, CDCES, and Nimish Patel, PharmD, PhD, AAHIVP, discuss exciting new data on HIV care and prevention from CROI 2024 and learn how to integrate these data into your practice to optimize HIV prevention and treatment.

Listen as Su Wang, MD, MPH, FACP; Richard R. Andrews, MD, MPH; Ruth Brogden, MPH; and Amy S. Tang, MD, explore how early and sustained HBV care can be enhanced by expanding the role of primary care providers.

Learn from Gregory Huhn, MD, MPHTM, about why sometimes viral suppression is not enough to achieve optimal health outcomes for people living with HIV. Listen in as we explore optimizing ART to address internalized stigma in the setting of virologic suppression.

In episode 3 of this ongoing series, listen to a patient with CHB share with her hepatologist, Maria Buti, MD, how she was first diagnosed with HBV and her journey navigating the healthcare system. The conversation includes insights on how to improve HBV screening and transitions of care.

Joseph J. Eron, Jr., MD, and Monica Gandhi, MD, MPH, discuss the most clinically relevant new data presented at CROI 2024, including long-acting ART, comorbidities and coinfections, and what’s on the horizon in HIV treatment.

Listen as Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, review strategies for more expansive HBV treatment while considering adverse events, cost-effectiveness, and patient perspectives.

In episode 2 of this ongoing series, listen to a person with HBV converse with hepatologist, Robert Wong, MD, MS, about strategies for healthcare professionals to improve patient education and cultural considerations that may delay HBV diagnosis and care.

Listen to Roger Bedimo, MD, MS, FACP, discuss considerations for older people living with HIV, including polypharmacy and deprescribing, the risk of cardiovascular events with various ART regimens, and approaches for managing weight gain.

Listen to Roger Bedimo, MD, discuss best practices for individualized care in transgender women living with HIV, including providing services in a gender-affirmative care model, proactive counseling on drug–drug interactions with gender-affirming hormone therapy, and strategies to reduce adverse events.

Listen to Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, describe how to optimize outpatient COVID-19 antiviral therapy, discuss how to assess and manage drug-drug interactions with COVID-19 antivirals using available resources, and answer learner’s most pressing questions about this topic.

Hear expert analysis from Nancy Reau, MD, on the latest data presented at AASLD 2023 on hepatitis B management, including current treatment options and novel agents under investigation for functional cure.

Are you inadvertently compromising your patients’ persistence on PrEP? Hear from Dr LaRon E. Nelson in this case-based discussion on the role that you, as the healthcare professional, may be playing and strategies you can implement to modify your approach to encourage persistence.

In episode 1 of this ongoing series, listen to a patient discuss her experiences living with HBV and HDV with her hepatologist, Nancy Reau, MD. The conversation includes insights on opportunities to optimize patient care and considerations for clinical trial participation.

David Saunders, an HIV PrEP user and advocate, discusses the value of nonstigmatizing discussions between people using PrEP and healthcare professionals to individualize adherence strategies and encourage PrEP persistence.

Hear from Sarah M. Wood, MD, MS, in this case-based discussion of the data and recommendations for initiating long-acting PrEP for a transgender adolescent patient as a strategy to support PrEP persistence and engagement.

Listen to Angela Branche, MD, share her perspective on why healthcare professionals should consider a risk-based approach—rather than age alone—to determine RSV vaccine candidacy in adults.